Warby Parker (WRBY) | Financial Analysis & Statements
Warby Parker Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
212.0M
Gross Profit
111.0M
52.39%
Operating Income
-6.9M
-3.23%
Net Income
-6.0M
-2.81%
EPS (Diluted)
$-0.05
Balance Sheet Metrics
Total Assets
720.9M
Total Liabilities
353.2M
Shareholders Equity
367.7M
Debt to Equity
0.96
Cash Flow Metrics
Operating Cash Flow
46.8M
Free Cash Flow
8.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Warby Parker Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 871.9M | 771.3M | 669.8M | 598.1M | 540.8M |
| Cost of Goods Sold | 401.3M | 344.5M | 304.5M | 257.0M | 223.0M |
| Gross Profit | 470.6M | 426.8M | 365.2M | 341.1M | 317.7M |
| Gross Margin % | 54.0% | 55.3% | 54.5% | 57.0% | 58.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 475.9M | 456.9M | 437.2M | 452.3M | 461.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 475.9M | 456.9M | 437.2M | 452.3M | 461.4M |
| Operating Income | -5.3M | -30.1M | -72.0M | -111.2M | -143.7M |
| Operating Margin % | -0.6% | -3.9% | -10.7% | -18.6% | -26.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 3.0M | -19.5M | -62.8M | -109.9M | -144.0M |
| Income Tax | 1.4M | 875.0K | 433.0K | 497.0K | 263.0K |
| Effective Tax Rate % | 46.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 1.6M | -20.4M | -63.2M | -110.4M | -144.3M |
| Net Margin % | 0.2% | -2.6% | -9.4% | -18.5% | -26.7% |
| Key Metrics | |||||
| EBITDA | 44.9M | 15.8M | -33.4M | -79.3M | -122.1M |
| EPS (Basic) | - | $-0.17 | $-0.54 | $-0.96 | $-2.21 |
| EPS (Diluted) | - | $-0.17 | $-0.54 | $-0.96 | $-2.21 |
| Basic Shares Outstanding | - | 120385000 | 117389012 | 114942019 | 71249257 |
| Diluted Shares Outstanding | - | 120385000 | 117389012 | 114942019 | 71249257 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Warby Parker Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 286.4M | 254.2M | 216.9M | 208.6M | 256.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 3.3M | 1.9M | 1.8M | 1.4M | 992.0K |
| Inventory | 44.5M | 52.3M | 62.2M | 68.8M | 57.1M |
| Other Current Assets | 18.3M | 17.6M | 17.7M | 15.7M | 13.5M |
| Total Current Assets | 352.4M | 326.0M | 298.6M | 294.6M | 328.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 170.8M | 171.3M | 122.3M | 127.0M | 0 |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 10.2M | 8.7M | 7.1M | 8.5M | 471.0K |
| Total Non-Current Assets | 368.5M | 350.4M | 281.7M | 274.1M | 112.7M |
| Total Assets | 720.9M | 676.5M | 580.3M | 568.7M | 440.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 32.0M | 23.5M | 22.5M | 20.8M | 30.9M |
| Short-term Debt | 31.4M | 20.2M | 24.3M | 22.5M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.7M | 2.6M | 2.4M | 2.4M | 4.3M |
| Total Current Liabilities | 150.1M | 130.4M | 127.1M | 129.6M | 118.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 201.7M | 205.1M | 150.2M | 150.8M | 0 |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 1.3M | 943.0K | 1.3M | 1.7M | - |
| Total Non-Current Liabilities | 203.1M | 206.1M | 151.4M | 152.5M | 36.5M |
| Total Liabilities | 353.2M | 336.4M | 278.5M | 282.1M | 154.6M |
| Equity | |||||
| Common Stock | 12.0K | 12.0K | 12.0K | 12.0K | 11.0K |
| Retained Earnings | -685.6M | -687.2M | -666.8M | -603.6M | -493.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 367.7M | 340.1M | 301.8M | 286.6M | 286.0M |
| Key Metrics | |||||
| Total Debt | 233.1M | 225.4M | 174.5M | 173.4M | 0 |
| Working Capital | 202.3M | 195.7M | 171.5M | 165.0M | 209.9M |
Balance Sheet Composition
Warby Parker Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.6M | -20.4M | -63.2M | -110.4M | -144.3M |
| Depreciation & Amortization | 50.3M | 45.9M | 38.6M | 31.9M | 21.6M |
| Stock-Based Compensation | 34.5M | 47.3M | 70.5M | 98.0M | 107.1M |
| Working Capital Changes | 25.9M | 13.0M | 18.0M | -7.0M | -27.1M |
| Operating Cash Flow | 118.6M | 91.6M | 69.9M | 16.5M | -34.9M |
| Investing Activities | |||||
| Capital Expenditures | -67.0M | -64.0M | -53.7M | -60.2M | -48.5M |
| Acquisitions | 0 | -2.0M | -1.0M | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -67.0M | -66.0M | -54.7M | -60.2M | -48.5M |
| Financing Activities | |||||
| Share Repurchases | - | - | 0 | 0 | -8.1M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 0 | 91.0K | 31.6M |
| Debt Repayment | - | - | - | 0 | 0 |
| Financing Cash Flow | -14.4M | 333.0K | 0 | 91.0K | 3.0M |
| Free Cash Flow | 43.7M | 34.7M | 7.3M | -49.8M | -80.5M |
| Net Change in Cash | 37.1M | 25.9M | 15.3M | -43.6M | -80.5M |
Cash Flow Trend
Warby Parker Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,281.00
Forward P/E
33.77
Price to Book
7.60
Price to Sales
3.20
PEG Ratio
-136.86
Profitability Ratios
Profit Margin
0.19%
Operating Margin
-4.54%
Return on Equity
0.46%
Return on Assets
-0.43%
Financial Health
Current Ratio
2.35
Debt to Equity
63.40
Beta
2.08
Per Share Data
EPS (TTM)
$0.01
Book Value per Share
$3.00
Revenue per Share
$7.11
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WRBY | 2.8B | 2,281.00 | 7.60 | 0.46% | 0.19% | 63.40 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






